Literature DB >> 15108984

Peripheral nerve injury sensitizes the response to visceral distension but not its inhibition by the antidepressant milnacipran.

Sang-Wook Shin1, James C Eisenach.   

Abstract

BACKGROUND: Manipulations that cause hypersensitivity to visceral stimuli have been shown to also result in hypersensitivity to somatic stimuli coming from convergent dermatomes, but the converse has not been examined. The authors tested whether lumbar spinal nerve ligation in rats, a common model of neuropathic pain that results in hypersensitivity to somatic stimuli, also leads to hypersensitivity to visceral stimuli coming from convergent dermatomes and whether pharmacology of inhibition differed between these two sensory modalities.
METHODS: Female Sprague-Dawley rats were anesthetized, and the left L5 and L6 spinal nerves were ligated. Animals received either intrathecal saline or milnacipran (0.1-3 microg), and withdrawal thresholds to mechanical testing in the left hind paw, using von Frey filaments, and visceral testing, using balloon colorectal distension, were determined.
RESULTS: Nerve ligation resulted in decreases in threshold to withdrawal to somatic mechanical stimulation (from 13 +/- 1.8 g to 2.7 +/- 0.7 g) and also in decreases in threshold to reflex response to visceral stimulation (from 60 mmHg to 40 mmHg). Intrathecal milnacipran increased withdrawal threshold to somatic stimulation in a dose-dependent manner but failed to alter the response to noxious visceral stimulation.
CONCLUSIONS: Injury of nerves innervating somatic structures enhances nociception from stimulation of viscera with convergent input from nearby dermatomes, suggesting that somatic neuropathic pain could be accompanied by an increased likelihood of visceral pain. Lack of efficacy of the antidepressant milnacipran against visceral stimuli suggests that visceral hypersensitivity may not share the same pharmacology of inhibition as somatic hypersensitivity after nerve injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15108984     DOI: 10.1097/00000542-200403000-00030

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  3 in total

1.  Effects of milnacipran, a 5-HT and noradrenaline reuptake inhibitor, on C-fibre-evoked field potentials in spinal long-term potentiation and neuropathic pain.

Authors:  S Ohnami; A Kato; K Ogawa; S Shinohara; H Ono; M Tanabe
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

2.  Milnacipran inhibits glutamatergic N-methyl-D-aspartate receptor activity in spinal dorsal horn neurons.

Authors:  Tatsuro Kohno; Masafumi Kimura; Mika Sasaki; Hideaki Obata; Fumimasa Amaya; Shigeru Saito
Journal:  Mol Pain       Date:  2012-06-19       Impact factor: 3.395

3.  Evaluation of the neurological safety of epidural milnacipran in rats.

Authors:  Seung Mo Lim; Mee Ran Shin; Kyung Ho Kang; Hyun Kang; Francis Sahngun Nahm; Baek Hui Kim; Hwa Yong Shin; Young Jin Lim; Sang Chul Lee
Journal:  Korean J Pain       Date:  2012-10-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.